China’s equity market appears to be moving into a repricing phase after several years defined by volatility, declining confidence, and compressed valuations. Rather than a sharp rebound or a renewed selloff, current market behavior suggests a slower reassessment of what Chinese assets are
After a prolonged period of withdrawal, global investors are cautiously finding their way back into Chinese equity markets. The shift is gradual rather than dramatic, reflecting a reassessment of risk rather than renewed enthusiasm. For many international funds, the move is less about
After years of volatility and persistent skepticism, China’s stock market is beginning to show tentative signs of renewed momentum. Recent policy signals from Beijing have helped ease investor anxiety, encouraging both domestic and international participants to reassess long held assumptions about risk, valuation,
Early weakness gives way to a measured recovery Mainland Chinese equities managed to recover from early losses on Thursday as investors reassessed policy signals from the country’s central bank. Markets opened cautiously, reflecting uncertainty over the outlook for monetary support, but sentiment gradually
A rally built on confidence and valuation Chinese equities have staged a strong recovery over the past year, driven largely by improving sentiment rather than dramatic changes in corporate fundamentals. As confidence returned to markets, valuation multiples expanded, lifting share prices even as
Investor nerves rattled by planned stock disposal Shares of Xiaomi came under pressure after the company disclosed that its co founder and vice chairman plans to sell a substantial portion of his holdings in the coming years. The announcement unsettled investors who are
A cautious start to the final trading sessions Hong Kong equities opened the final two and a half trading days of the year on a subdued note as investors scaled back activity ahead of the New Year holiday. With many market participants already
Swiss investment bank UBS has cautioned that global financial markets may face significantly higher volatility next year. During a recent press conference, the bank outlined several risks that could shake investor confidence in 2026, ranging from slowing economic growth to geopolitical instability. Despite
Chinese biopharmaceutical company 3SBio has launched a major fundraising effort as it aims to strengthen its drug development pipeline and expand its global footprint. The Shenyang-based firm announced plans to raise HK$3.12 billion, or roughly US$401 million, through a new share placement in
There is an old saying that history does not repeat itself, but it often rhymes. In most areas of life, that may be true, but when it comes to real estate and the stock market, history behaves in a much more predictable way.
